Skip to main content
Erschienen in:

01.12.2010

Cytochrome P450 Pathway Contributes to Methanandamide-induced Vasorelaxation in Rat Aorta

verfasst von: Visitación López-Miranda, M. Teresa Dannert, Esperanza Herradón, Angela Alsasua, M. Isabel Martín

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 5-6/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The generation of hyperpolarising vasorelaxant endothelial cytochrome P450 epoxygenase (CYP)—derived metabolites of arachidonic may provide beneficial effects for the treatment of cardiovascular diseases in which the bioavailability of NO is impaired. The cannabinoid methanandamide has vasodilatory properties linked to hyperpolarisation. The aim of the present work was to investigate the vasorelaxant effects of methanandamide in rat aorta, focusing on the role of cytochrome P450 pathway.

Methods

Changes in isometric tension in response to a cumulative concentration-response curve of methanandamide (1 nM–100 μM) were recorded in aortic rings from male Wistar rats. The involvement of cannabinoid receptors, endothelial nitric oxide (NO)-, prostacyclin- and some hyperpolarising-mediated pathways were investigated. The activation of large-conductance Ca2+-activated K+ (BKCa) channels have also been evaluated.

Results

Methanandamide provoked an endothelium-dependent vasorelaxation in rat aorta, reaching a maximal effect (Rmax) of 67% ± 2.6%. This vasorelaxation was clearly inhibited by the combination of CB1 and CB2 cannabinoid antagonists (Rmax: 21.6% ± 1.3%) and by the combination of guanylate cyclase and CYP inhibitors (Rmax: 16.7% ± 1.1%). The blockade induced separately by guanylate cyclase (31.3% ± 2.8%) or CYP (36.3% ± 6.6%) inhibitors on methanandamide vasorelaxation was not significantly modified by either CB1 or CB2 inhibition. BKCa channels inhibition caused a partial and significant inhibition of the methanandamide vasorelaxation (Rmax: 39.9% ± 3.3%).

Conclusions

Methanandamide endothelium-dependent vasorelaxation is mediated by CB1 and CB2 cannabinoid receptors. The NO- and CYP-mediated pathways contribute in a concurrent manner in this vascular effect. Stimulation of both cannabinoid receptor subtypes is indistinctly linked to NO or CYP routes to cause vasorelaxation.
Literatur
1.
Zurück zum Zitat Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:31–85. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:31–85.
2.
Zurück zum Zitat Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007;292:C996–C1012.PubMedCrossRef Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 2007;292:C996–C1012.PubMedCrossRef
3.
Zurück zum Zitat Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res. 2004;49:525–33.PubMedCrossRef Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res. 2004;49:525–33.PubMedCrossRef
4.
Zurück zum Zitat Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996;94:3341–7.PubMed Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996;94:3341–7.PubMed
5.
Zurück zum Zitat Hercule HC, Schunck WH, Gross V, et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol. 2009;29:54–60.PubMedCrossRef Hercule HC, Schunck WH, Gross V, et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol. 2009;29:54–60.PubMedCrossRef
6.
Zurück zum Zitat Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res. 2009;50:S52–6.PubMedCrossRef Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res. 2009;50:S52–6.PubMedCrossRef
7.
Zurück zum Zitat Kunos G, Járai Z, Bátkai S, et al. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids. 2000;108:159–68.PubMedCrossRef Kunos G, Járai Z, Bátkai S, et al. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids. 2000;108:159–68.PubMedCrossRef
8.
Zurück zum Zitat Randall MD, Harris D, Kendall DA, Ralevic V. Cardiovascular effects of cannabinoids. Pharmacol Ther. 2002;95:191–202.PubMedCrossRef Randall MD, Harris D, Kendall DA, Ralevic V. Cardiovascular effects of cannabinoids. Pharmacol Ther. 2002;95:191–202.PubMedCrossRef
9.
Zurück zum Zitat López-Miranda V, Herradón E, Martín MI. Vasorelaxation caused by cannabinoids: mechanisms in different vascular beds. Curr Vasc Pharmacol. 2008;6:335–46.CrossRef López-Miranda V, Herradón E, Martín MI. Vasorelaxation caused by cannabinoids: mechanisms in different vascular beds. Curr Vasc Pharmacol. 2008;6:335–46.CrossRef
10.
Zurück zum Zitat Dannert MT, Alsasua A, Herradón E, Martín MI, López-Miranda V. Vasorelaxant effect of Win 55, 212-2 in rat aorta: new mechanisms involved. Vascul Pharmacol. 2007;46:16–23.PubMedCrossRef Dannert MT, Alsasua A, Herradón E, Martín MI, López-Miranda V. Vasorelaxant effect of Win 55, 212-2 in rat aorta: new mechanisms involved. Vascul Pharmacol. 2007;46:16–23.PubMedCrossRef
11.
Zurück zum Zitat Herradón E, Martín MI, López-Miranda V. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol. 2007;152:699–708.PubMedCrossRef Herradón E, Martín MI, López-Miranda V. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol. 2007;152:699–708.PubMedCrossRef
12.
Zurück zum Zitat Grainger J, Boachie-Ansah G. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol. 2001;134:1003–12.PubMedCrossRef Grainger J, Boachie-Ansah G. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol. 2001;134:1003–12.PubMedCrossRef
13.
Zurück zum Zitat Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434–8.PubMedCrossRef Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424:434–8.PubMedCrossRef
14.
Zurück zum Zitat Ho WSV, Randall MD. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol. 2007;150:641–51.PubMedCrossRef Ho WSV, Randall MD. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol. 2007;150:641–51.PubMedCrossRef
15.
Zurück zum Zitat Kozłowska H, Baranowska M, Schlicker E, Kozłowski M, Laudañski J, Malinowska B. Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. Br J Pharmacol. 2008;155:1034–42.PubMedCrossRef Kozłowska H, Baranowska M, Schlicker E, Kozłowski M, Laudañski J, Malinowska B. Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. Br J Pharmacol. 2008;155:1034–42.PubMedCrossRef
16.
Zurück zum Zitat Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther. 1997;281:1030–7.PubMed Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther. 1997;281:1030–7.PubMed
17.
Zurück zum Zitat Malinowska B, Kwolek G, Göthert M. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 2001;364:562–9.CrossRef Malinowska B, Kwolek G, Göthert M. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 2001;364:562–9.CrossRef
18.
Zurück zum Zitat Wang Y, Kaminski NE, Wang DH. VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension. 2005;46:986–91.PubMedCrossRef Wang Y, Kaminski NE, Wang DH. VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension. 2005;46:986–91.PubMedCrossRef
19.
Zurück zum Zitat Vanheel B, Van de Voorde J. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J Pharmacol Exp Ther. 2001;296:322–8.PubMed Vanheel B, Van de Voorde J. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J Pharmacol Exp Ther. 2001;296:322–8.PubMed
20.
Zurück zum Zitat Breyne J, Vanheel B. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves. J Cardiovasc Pharmacol. 2006;47:303–9.PubMedCrossRef Breyne J, Vanheel B. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves. J Cardiovasc Pharmacol. 2006;47:303–9.PubMedCrossRef
21.
Zurück zum Zitat Sade H, Muraki K, Ohya S, Hatano N, Imaizumi Y. Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. Am J Physiol Cell Physiol. 2006;290:C77–86.PubMedCrossRef Sade H, Muraki K, Ohya S, Hatano N, Imaizumi Y. Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. Am J Physiol Cell Physiol. 2006;290:C77–86.PubMedCrossRef
22.
Zurück zum Zitat López-Miranda V, Herradón E, Dannert MT, Alsasua A, Martín MI. Anandamide vehicles: a comparative study. Eur J Pharmacol. 2004;505:151–61.PubMedCrossRef López-Miranda V, Herradón E, Dannert MT, Alsasua A, Martín MI. Anandamide vehicles: a comparative study. Eur J Pharmacol. 2004;505:151–61.PubMedCrossRef
23.
Zurück zum Zitat Zhao J, Majewski H. Endothelial nitric oxide attenuates Na+/Ca2+ exchanger-mediated vasoconstriction in rat aorta. Br J Pharmacol. 2008;154:982–90.PubMedCrossRef Zhao J, Majewski H. Endothelial nitric oxide attenuates Na+/Ca2+ exchanger-mediated vasoconstriction in rat aorta. Br J Pharmacol. 2008;154:982–90.PubMedCrossRef
24.
Zurück zum Zitat Van der Zypp A, Kang KB, Majewski H. Age-related involvement of the endothelium in b-adrenoceptor-mediated relaxation of rat aorta. Eur J Pharmacol. 2000;397:129–38.PubMedCrossRef Van der Zypp A, Kang KB, Majewski H. Age-related involvement of the endothelium in b-adrenoceptor-mediated relaxation of rat aorta. Eur J Pharmacol. 2000;397:129–38.PubMedCrossRef
25.
Zurück zum Zitat Woodman OL, Malakul W. 3′, 4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci. 2009;85:54–9.PubMedCrossRef Woodman OL, Malakul W. 3′, 4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci. 2009;85:54–9.PubMedCrossRef
26.
Zurück zum Zitat Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension. 1999;33:429–34.PubMed Wagner JA, Varga K, Jarai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension. 1999;33:429–34.PubMed
27.
Zurück zum Zitat Wagner JA, Jarai Z, Bátkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors. Eur J Pharmacol. 2001;423:203–10.PubMedCrossRef Wagner JA, Jarai Z, Bátkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors. Eur J Pharmacol. 2001;423:203–10.PubMedCrossRef
28.
Zurück zum Zitat Ralevic V, Kendall DA, Zygmunt PM, Movahed P, Högestätt ED. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed. Br J Pharmacol. 2000;130:1483–8.PubMedCrossRef Ralevic V, Kendall DA, Zygmunt PM, Movahed P, Högestätt ED. Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed. Br J Pharmacol. 2000;130:1483–8.PubMedCrossRef
29.
Zurück zum Zitat Breyne J, Van de Voorde J, Vanheel B. Characterization of the vasorelaxation to methanandamide in rat gastric arteries. Can J Physiol Pharmacol. 2006;84:1121–32.PubMedCrossRef Breyne J, Van de Voorde J, Vanheel B. Characterization of the vasorelaxation to methanandamide in rat gastric arteries. Can J Physiol Pharmacol. 2006;84:1121–32.PubMedCrossRef
30.
Zurück zum Zitat Mukhopadhyay S, Chapnick BM, Howlett AC. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol Heart Circ Physiol. 2002;282:H2046–54.PubMed Mukhopadhyay S, Chapnick BM, Howlett AC. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol Heart Circ Physiol. 2002;282:H2046–54.PubMed
31.
Zurück zum Zitat Randall MD, Kendall DA, O’Sullivan S. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol. 2004;142:20–6.PubMedCrossRef Randall MD, Kendall DA, O’Sullivan S. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol. 2004;142:20–6.PubMedCrossRef
32.
Zurück zum Zitat Mukhopadhyay S, Howlett AC. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions. Mol Pharmacol. 2005;67:2016–24.PubMedCrossRef Mukhopadhyay S, Howlett AC. Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions. Mol Pharmacol. 2005;67:2016–24.PubMedCrossRef
33.
Zurück zum Zitat Wagner JA, Abesser M, Karcher J, Laser M, Kunos G. Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. J Cardiovasc Pharmacol. 2005;46:348–55.PubMedCrossRef Wagner JA, Abesser M, Karcher J, Laser M, Kunos G. Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. J Cardiovasc Pharmacol. 2005;46:348–55.PubMedCrossRef
34.
Zurück zum Zitat Járai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endotelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA. 1999;96:14136–41.PubMedCrossRef Járai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endotelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA. 1999;96:14136–41.PubMedCrossRef
35.
Zurück zum Zitat Mendizabal VE, Orliac ML, Adler-Graschinsky E. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. Eur J Pharmacol. 2001;427:251–62.PubMedCrossRef Mendizabal VE, Orliac ML, Adler-Graschinsky E. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. Eur J Pharmacol. 2001;427:251–62.PubMedCrossRef
36.
Zurück zum Zitat Högestätt ED, Zygmung PM. Cardiovascular pharmacology of anandamide. Prostaglandins Leukot Essent Fatty Acids. 2002;66:343–51.PubMedCrossRef Högestätt ED, Zygmung PM. Cardiovascular pharmacology of anandamide. Prostaglandins Leukot Essent Fatty Acids. 2002;66:343–51.PubMedCrossRef
37.
Zurück zum Zitat Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol. 2005;568:539–51.PubMedCrossRef Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro-Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol. 2005;568:539–51.PubMedCrossRef
38.
Zurück zum Zitat McCollum L, Howlett AC, Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther. 2007;321:930–7.PubMedCrossRef McCollum L, Howlett AC, Mukhopadhyay S. Anandamide-mediated CB1/CB2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J Pharmacol Exp Ther. 2007;321:930–7.PubMedCrossRef
39.
Zurück zum Zitat Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, Jiang H, et al. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem. 2007;282:2891–8.PubMedCrossRef Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, Jiang H, et al. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem. 2007;282:2891–8.PubMedCrossRef
40.
Zurück zum Zitat Gollasch M, Wellman GC, Knot HJ, Jaggar JH, Damon DH, Bonev AD, et al. Ontogeny of loval sarcoplasmic reticulum Ca2+ signals in cerebral arteries: Ca2+ sparks as elementary physiological events. Circ Res. 1998;83:1104–14.PubMed Gollasch M, Wellman GC, Knot HJ, Jaggar JH, Damon DH, Bonev AD, et al. Ontogeny of loval sarcoplasmic reticulum Ca2+ signals in cerebral arteries: Ca2+ sparks as elementary physiological events. Circ Res. 1998;83:1104–14.PubMed
41.
Zurück zum Zitat Lohn M, Jessner W, Furstenau M, et al. Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res. 2001;89:1051–7.PubMedCrossRef Lohn M, Jessner W, Furstenau M, et al. Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res. 2001;89:1051–7.PubMedCrossRef
42.
Zurück zum Zitat Félétou M. Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol. 2009;156:545–62.PubMedCrossRef Félétou M. Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol. 2009;156:545–62.PubMedCrossRef
43.
Zurück zum Zitat Busse R, Edward G, Félétou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23:374–80.PubMedCrossRef Busse R, Edward G, Félétou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23:374–80.PubMedCrossRef
44.
Zurück zum Zitat Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215–25.PubMedCrossRef Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215–25.PubMedCrossRef
45.
Zurück zum Zitat Yang Z, Zhang A, Altura BT, Altura BM. Hydrogen peroxide-induced endothelium-dependent relaxation of rat aorta involvement of Ca2+ and other cellular metabolites. Gen Pharmacol. 1999;33:325–36.PubMedCrossRef Yang Z, Zhang A, Altura BT, Altura BM. Hydrogen peroxide-induced endothelium-dependent relaxation of rat aorta involvement of Ca2+ and other cellular metabolites. Gen Pharmacol. 1999;33:325–36.PubMedCrossRef
46.
Zurück zum Zitat Chen JK, Chen J, Imig JD, et al. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. J Biol Chem. 2008;283:24514–24.PubMedCrossRef Chen JK, Chen J, Imig JD, et al. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. J Biol Chem. 2008;283:24514–24.PubMedCrossRef
Metadaten
Titel
Cytochrome P450 Pathway Contributes to Methanandamide-induced Vasorelaxation in Rat Aorta
verfasst von
Visitación López-Miranda
M. Teresa Dannert
Esperanza Herradón
Angela Alsasua
M. Isabel Martín
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 5-6/2010
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-010-6261-9

Weitere Artikel der Ausgabe 5-6/2010

Cardiovascular Drugs and Therapy 5-6/2010 Zur Ausgabe

Neu im Fachgebiet Kardiologie

Nach dem Nitrospray fünf Minuten mit der Kardio-CT warten!

19.07.2024 Koronare Herzerkrankung Nachrichten

Nach Verabreichung von sublingualem Nitrospray vor einer CT-Koronarangiografie sollte man unbedingt die in Leitlinien empfohlene Wartezeit einhalten, rät ein kardiologisches Team aus Belgien.

Welche Antikoagulation bei Vorhofflimmern und Leberzirrhose?

19.07.2024 Leberzirrhose Nachrichten

Bei einer Auswertung von US-Versicherungsdaten ging es um die Frage, welche Antikoagulation –  Apixaban, Rivaroxaban oder Warfarin – bei Personen mit Leberzirrhose und Vorhofflimmern unterm Strich die beste Prophylaxe-Option ist.     

Mehrgefäßstenosen einzeitig oder zweizeitig eröffnen?

18.07.2024 Gefäßstenosen Nachrichten

Nach einem Herzinfarkt mit Mehrgefäßerkrankung sind bessere Ergebnisse zu erwarten, wenn alle stenotischen Abschnitte revaskularisiert werden. Sollte das in einer oder in mehreren Sitzungen geschehen? Eine Metaanalyse gibt eine klare Antwort.

Erste zielgerichtete Therapie zur Behandlung der hypertrophen obstruktiven Kardiomyopathie

18.07.2024 Kardiomyopathie Nachrichten

Mit Mavacamten von Bristol Myers Squibb ist erstmals eine zielgerichtete Therapie der hypertrophen obstruktiven Kardiomyopathie (HOCM) verfügbar. Der Myosin-Inhibitor verhindert die bei HOCM übermäßige Bildung von Aktin-Myosin-Querbrücken und verbessert die Symptomatik und die Lebensqualität von Betroffenen.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.